The effects of orlistat on metabolic parameters and other cardiovascular risk factors.
about
Identification of novel inhibitors of dietary lipid absorption using zebrafishGelidium elegans Regulates the AMPK-PRDM16-UCP-1 Pathway and Has a Synergistic Effect with Orlistat on Obesity-Associated Features in Mice Fed a High-Fat DietDoes combination therapy with statins and fibrates prevent cardiovascular disease in diabetic patients with atherogenic mixed dyslipidemia?Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients?Combination drug treatment in obese diabetic patientsEffect of orlistat alone or in combination with Garcinia cambogia on visceral adiposity index in obese patients.Effect of various treatments on leptin, adiponectin, ghrelin and neuropeptide Y in patients with type 2 diabetes mellitus.Combinations of ezetimibe with nonstatin drug regimens affecting lipid metabolism.The uric acid metabolism pathway as a therapeutic target in hyperuricemia related to metabolic syndrome.Roles of the gut in the metabolic syndrome: an overview.Comparison of orlistat treatment and placebo in obese type 2 diabetic patients.Efficacy and safety of ezetimibe plus orlistat or rimonabant in statin-intolerant nondiabetic overweight/obese patients with dyslipidemia.Addition of a low dose of rimonabant to orlistat therapy decreases weight gain and reduces adiposity in dietary obese rats.The Effect of Consumption of Citrus Fruit and Olive Leaf Extract on Lipid Metabolism.An open-label pilot study of the combination therapy of metformin and fluoxetine for weight reduction.Effects of PCSK9 Inhibitors on Other than Low-Density Lipoprotein Cholesterol Lipid Variables.Short-term administration of orlistat reduced daytime triglyceridemia in obese women with the metabolic syndrome.
P2860
Q28475286-3E19D293-C389-4A70-8FD6-62FC51BEA991Q33616651-98543786-7EDE-45E0-B220-8912E818F5CAQ33776187-B55E69A2-5484-4AC9-949D-875A938BBDC2Q34591803-15664B5D-7300-400F-9175-4C2CE88F71F8Q34877652-83F75288-2F88-40B9-B813-DA0C68575EBBQ37334443-FF5FBA48-C5E7-4DC4-B7A4-6B84E3849EDFQ37831911-35ACD218-8DDC-4AB4-91CA-7FA31D9F5D4FQ37857866-B27BFD8B-F084-4678-B362-1CE44089F3A3Q38047387-DF254D70-61C4-42B7-A7B6-8C9B4E94E087Q38780926-24F4D7F8-5A9C-4A6C-8E3F-D0FC8FBADFFAQ43009560-3CB3852F-EA01-4299-AC26-399DE98FC59AQ43282311-66FAA820-E13C-444D-9BD7-44AA2FAAE044Q44066771-C51A5C75-8F5A-4543-AA91-F2A954CED7F9Q47161793-62E0F476-9227-4BE7-A864-161FDCD1ACE9Q47321829-2A204A6E-2582-4444-AE23-98FD5049490CQ48209248-08AE089C-796C-4672-8D8E-54190ECC49B3Q51475958-B6A9489C-A5E1-4EA3-912B-32294D1C7BF9
P2860
The effects of orlistat on metabolic parameters and other cardiovascular risk factors.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The effects of orlistat on metabolic parameters and other cardiovascular risk factors.
@ast
The effects of orlistat on metabolic parameters and other cardiovascular risk factors.
@en
type
label
The effects of orlistat on metabolic parameters and other cardiovascular risk factors.
@ast
The effects of orlistat on metabolic parameters and other cardiovascular risk factors.
@en
prefLabel
The effects of orlistat on metabolic parameters and other cardiovascular risk factors.
@ast
The effects of orlistat on metabolic parameters and other cardiovascular risk factors.
@en
P1476
The effects of orlistat on metabolic parameters and other cardiovascular risk factors
@en
P2093
D N Kiortsis
P356
10.1016/S1262-3636(07)70161-1
P577
2005-02-01T00:00:00Z